What's breaking now, across thousands of outlets.
As GLP-1 use rises, coverage is becoming a powerful recruiting and retention tool, forcing employers to weigh drug costs against the price of losing talent.
We haven't written up this one. Inc. has the full story — the link below goes straight to it.
1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its novel pop-up cardboard inhaler towards first regulatory approval.
Ulrich Ladurner has created a world market leader for gluten-free food. In an interview, he explains how he opens up new markets and how he views Germany and the USA.
Democrats are poised to romp in today's election — easily winning the House and, according to most forecasts, flipping the Senate too. Yet the party itself is less popular than the IRS .
The Federal Network Agency has decided where new gas power plants are to be built. The most are planned in North Rhine-Westphalia, followed by Brandenburg, Saxony and Bavaria.
Oando Plc reduced its borrowings to N2.16 trillion, 22 percent below the peak at the end of 2024. The Nigerian energy
